Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT06443034
Eligibility Criteria:
Inclusion Criteria:
* Adult patients followed in 6 nephrology centers between 01/01/2016 and 01/06/2024.
* With characterization of APOL1 gene risk status
* Proteinuria/creatinuria ratio \> 3 g/g at diagnosis of renal disease (within 48 hours of the diagnostic renal biopsy)
* Hypoalbuminemia \< 30 g/L at diagnosis of renal disease (within 48 h of diagnostic renal biopsy)
* Minimal change disease or segmental and focal hyalinosis lesions on renal biopsy.
Exclusion Criteria:
* Presence of diffuse deposits of immunoglobulins or complement fractions on immunofluorescence study
* Presence of endo- or extracapillary hypercellular lesions on light microscopy
* Opposition to the use of medical data
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06443034
Study Brief:
Protocol Section:
NCT06443034